Role of NF-κb-mediated interleukin-8 expression in intraocular neovascularization

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 7, 1998, Pages 1097-1106

  Yoshida, Ayako ^a   Yoshida, Shigeo ^a   Khalil, Abmad K ^a   Ishibashi, Tatsuro ^a   Inomata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PYRROLIDINE DITHIOCARBAMATE; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MESSENGER RNA; PRIMER DNA; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE INDUCTION; GLIA CELL; HUMAN; HUMAN TISSUE; HYPOXIC CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITREOUS BODY; ANIMAL; ANOXIA; CATTLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; GENETICS; GLIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANOXIA; AQUEOUS HUMOR; CATTLE; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; LYMPHOKINES; NEUROGLIA; NF-KAPPA B; POLYMERASE CHAIN REACTION; PYRROLIDINES; RETINAL NEOVASCULARIZATION; RNA, MESSENGER; THIOCARBAMATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 0031596117     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease. Trans Opbtbalmol Soc UK. 1948;68:137-180.
2. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engt J Med. 1994;331:1480-1487.
3. Malecaze F, Claraens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112:1476-1482.
4. Folkman J, Klagsbrum M. Angiogenic factors. Science. 1987;235: 442-447.
5. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
6. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun. 1993;61:4569-4574.
7. Fierer J, Eckmann L, Kagnoff M. Interleukin-8 secreted by epithelial cells invaded by bacteria. Infect Agents Dis. 1993;2:255-258.
8. Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest. 1995;95:55-65.
9. Rasmussen SJ, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest. 1997;99:77-87.
10. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992;258:1798-1801.
11. Stricter RM, Kunkel SL, Einer VM, et al. Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol. 1992;141: 1279-1284.
12. Wakabayashi Y, Shono T, Isono M, et al. Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/basic libroblast growth factor and interleukin-8. Jpn J Cancer Res. 1995;86:1189-1197.
13. Endo H, Akahoshi T, Nishimura A, et al. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clin Exp Immunol. 1994;96:31-35.
14. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol. 1994;144:820-828.
15. Singh RK, Gutman M, Reich R, Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 1995; 55:3669-3674.
16. Stricter RM, Polverini PJ, Arenberg DA, et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Lenkoc Biol. 1995;57:752-762.
17. Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med. 1994;179:1409-1415.
18. Einer SG, Einer VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res. 1995;14:1045-1053.
19. de BJ, Hack CE, Verhoeven AJ, et al. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders. Invest Ophthalmol Vis Sci. 1993;34:3376-3385.
20. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA. 1993;90:10193-10197.
21. Mukaida N, Monta M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem. 1994;269:13289-13295.
22. Oliveira IC, Mukaida N, Matsushima K, Vilcek J. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site. Mol Cell Biol. 1994;14:5300-5308.
23. Baeuerle PA. The itiducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta. 1991; 1072:63-80.
24. Grilli M, Chiu JJ-S, Lenardo MJ. NF-κB, and rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993; 143:1-62.
25. Lenardo MJ, Baltimore D. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229.
26. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ. Geneticcontrol of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91:2572-2579.
27. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Inivest. 1994;94:877-884.
28. Shono T, Ono M, Izumi H, et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol. 1996;16: 4231-4239.
29. Stoltz RA, Abraham NG, Laniado-Schwartzman M. The role of NF-kappaB in the angiogenic response of coronary microvessel endothelial cells. Proc Natl Acad Sci USA. 1996;93:2832-2837.
30. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor and basic nbroblast growth factor in tumor necrosis factor-α dependent angiogenesis. Mol Cell Biol. 1997;17:4015-4023.
31. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 1990;265:21128-21133.
32. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanism of interleukin-8 gene expression. J Leukocy Biol. 1994;56:554-558.
33. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem. 1993;268:25568-25576.
34. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 1994;12:141-179.
35. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem. 1992;267:16323-16329.
36. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 1992;176:1583-1593.
37. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996:93:9114-9119.
38. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-I) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
39. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxie induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 1994;93:1564-1570.
40. Hsu SU-M, Raine L, Fanger H. Lise of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 198129:577-580.
41. Hata Y, Nakagawa K, Ishibashi T, Inomata H, Ueno H, Sueishi K. Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Arch. 1995;426:479-486.
42. Gross JL, Moscatelli D, Jaffe EA, Rifkin DB. Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol. 1982;95:974-981.
43. Ryuto M, Ono M, Izumi H, et al Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells: possible roles of SP-1. J Biol Chem. 1996;271:28220-28228.
44. Abe T, Okamura K, Ono M, et al. Induction of vascular endothelial tubular morphogenesis by human gltoma cells: a model system for tumor angiogencsis. J Clin Invest. 1993;92:54-61.
45. Ohtsuka T, Kubota A, Hirano T, et al. Glucocoiticoid-mediated gene suppression of rat cytokinc-induced neutrophil chemoattractant CINC/gro, a member of the interlcukin-8 family, through impairment of NF-κB activation. J Biol Chem. 1996;271:1651-1659.
46. Morsey MA, Popowych Y, Kowalski J, et al. Molecular cloning and expression of bovine interleukin-8. Microb Pathogenesis. 1996;20: 203-212.
47. Leung DW, Cachianes G, Kuang W-J, Goeddel DM, Ferrara N. Vascular endothclial growth factor is a secreted angiogenic initogen. Science. 1989;246:1306-1309.
48. Hutchinson LE, Stevens MG, Olsen SC. Cloning bovine cytokine cDNA fragments and measuring bovine cytokine mRNA using the reverse transcription-polymerase chain reaction. Vet Immunol Immunopathol. 1994;44:13-29.
49. Garrido C, Saule S, Gospodarowicz D, Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors. 1993;8:109-117.
50. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Use of the polymcrase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry. 1990;29:10351-10356.
51. Nakayama H, Yokoi H, Fujita J. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res. 1992;20:4939.
52. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463-5467.
53. Montesano R, Kumar S, Orci L, Pepper MS. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest. 1996;75:249-262.
54. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biopbys Res Commun. 1993;191:1301-1308.
55. Ziegler HH, Sternsdorf T, Liese J, et al. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol. 1993;151:6986-6993.
56. Yoshida A, Yoshida S, Hata Y, Khalil AK, Ishibashi T, Inomata H. The role of NF-κB in retinal neovascularization in the rat: possible involvement of cytokine-induced ncutrophil chemoattractant (CINC), a member of the interleukin-8 family. J Histochem Cytochem. 1998;46:429-436.
57. Magargal LE, Donoso LA, Sanhom GE. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology. 1982;89:1241-1245.
58. Shimizu K, Kobayashi Y, Muraoka K. Midperipheral fundns involvement in diabetic retinopathy. Ophthalmology. 1981;88:601-612.
59. Tasman W, Magargal LE, Augsburger JJ. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology. 1980;87:400-402.
60. Laatikainen L, Blach RK. Behaviour of the iris vasculature in central retinal vein occlusion. Br J Ophthalmol. 1977;61:272-277.
61. Madsen PH. Ocular findings in 123 patients with proliferative diabetic retinopathy, I, Changes in the anterior segment of the eye. Doc Ophthalmol. 1971;29:331-343.
62. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
63. Gariano RF, Sage EH, Kaplan HJ, Hendrickson AE. Development of astrocytes and their relation to blood vessels in fetal monkey retina. Invest Ophthalmol Vis Sci. 1996;37:2367-2375.
64. Schmedtje JF Jr, Ji Y-S, Liu W-L, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601-608.
65. Muraoka K, Shimizu K, Sun X, et al. Hypoxia, but not reoxygenation, induces interleukin 6 gene expression through NF-kappa B activation. Transplantation. 1997;63:466-470.
66. Simorre-Pinatel V, Guerrin M, Chollet P, et al. Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci. 1994;35:3393-3400.
67. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604-4613.
68. Patterson C, Perrella MA, Hsieh CM, Yoshizumi M, Lee ME, Haber E. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem. 1995;270:23111-23118.